These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE). Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356 [TBL] [Abstract][Full Text] [Related]
3. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors]. Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549 [No Abstract] [Full Text] [Related]
4. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis. Kasi A; Abbasi S; Handa S; Al-Rajabi R; Saeed A; Baranda J; Sun W JAMA Netw Open; 2020 Dec; 3(12):e2030097. PubMed ID: 33326026 [TBL] [Abstract][Full Text] [Related]
5. Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers. John AO; Singh A; Bala D; Joel A; Georgy JT; Jesudasan MR; Mittal R; Ram TS; Reddy JR; Murthy A; Chandramohan A; Eapen A; Masih D; Ramnath N; Dobrosotskaya I; Yadav B; Chacko RT J Gastrointest Cancer; 2024 Mar; 55(1):307-317. PubMed ID: 37479897 [TBL] [Abstract][Full Text] [Related]
6. Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial. De Felice F; D'Ambrosio G; Iafrate F; Gelibter A; Magliocca FM; Musio D; Caponetto S; Casella G; Clementi I; Picchetto A; Sirgiovani G; Parisi M; Orciuoli C; Torrese G; De Toma G; Tombolini V; Cortesi E Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):788-794. PubMed ID: 34176711 [TBL] [Abstract][Full Text] [Related]
7. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis. Ye W; Shi L; Qian L; Sun Y; Sun X Cancer Rep (Hoboken); 2019 Oct; 2(5):e1188. PubMed ID: 32721108 [TBL] [Abstract][Full Text] [Related]
8. Disease Control, Survival, and Toxicity Outcome After Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Single-Institution Experience. De Felice F; Musio D; Magnante AL; Bulzonetti N; Benevento I; Caiazzo R; Tombolini V Clin Colorectal Cancer; 2016 Jun; 15(2):e17-22. PubMed ID: 26952656 [TBL] [Abstract][Full Text] [Related]
9. Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial. Masi G; Vivaldi C; Fornaro L; Lonardi S; Buccianti P; Sainato A; Marcucci L; Martignetti A; Luca Urso ED; Castagna M; Fontanini G; Bergamo F; Musettini G; Urbani L; Sensi E; Balestri R; Montrone S; Pasqualetti F; Cremolini C; Di Paolo A; Zagonel V; Falcone A Eur J Cancer; 2019 Mar; 110():32-41. PubMed ID: 30739838 [TBL] [Abstract][Full Text] [Related]
10. Pathologic Complete Response, Total Neoadjuvant Therapy and the Survival Paradox in Locally Advanced Rectal Cancer. Goffredo P; Suraju MO; Mott SL; Troester AM; Weaver L; Mishra A; Sokas C; Hassan I Ann Surg Oncol; 2024 Oct; 31(10):6432-6442. PubMed ID: 38814551 [TBL] [Abstract][Full Text] [Related]
11. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer. Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M J BUON; 2013; 18(2):385-90. PubMed ID: 23818350 [TBL] [Abstract][Full Text] [Related]
12. mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis. Ding M; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Xie X; Li J; Li W; Deng Y Clin Colorectal Cancer; 2022 Mar; 21(1):e12-e20. PubMed ID: 34963563 [TBL] [Abstract][Full Text] [Related]
13. Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial. Kim MJ; Lee DW; Kang HC; Park JW; Ryoo SB; Han SW; Kim KS; Chie EK; Oh JH; Jeong WK; Kim BH; Nam EM; Jeong SY BMC Cancer; 2023 Aug; 23(1):734. PubMed ID: 37553666 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07. Helbling D; Bodoky G; Gautschi O; Sun H; Bosman F; Gloor B; Burkhard R; Winterhalder R; Madlung A; Rauch D; Saletti P; Widmer L; Borner M; Baertschi D; Yan P; Benhattar J; Leibundgut EO; Bougel S; Koeberle D Ann Oncol; 2013 Mar; 24(3):718-25. PubMed ID: 23139259 [TBL] [Abstract][Full Text] [Related]
15. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis. Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant-intensified treatment for rectal cancer: time to change? Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials. Diefenhardt M; Fleischmann M; Martin D; Hofheinz RD; Piso P; Germer CT; Hambsch P; Grützmann R; Kirste S; Schlenska-Lange A; Ghadimi M; Rödel C; Fokas E; Radiother Oncol; 2023 Feb; 179():109455. PubMed ID: 36572280 [TBL] [Abstract][Full Text] [Related]
18. Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer. Kim JK; Marco MR; Roxburgh CSD; Chen CT; Cercek A; Strombom P; Temple LKF; Nash GM; Guillem JG; Paty PB; Yaeger R; Stadler ZK; Gonen M; Segal NH; Reidy DL; Varghese A; Shia J; Vakiani E; Wu AJ; Romesser PB; Crane CH; Gollub MJ; Saltz L; Smith JJ; Weiser MR; Patil S; Garcia-Aguilar J Oncologist; 2022 May; 27(5):380-388. PubMed ID: 35278070 [TBL] [Abstract][Full Text] [Related]
19. Total neoadjuvant therapy for locally advanced rectal cancer: a three-group propensity score matched study. Zhou J; Huang J; Zhou Z; Deng X; Wu Q; Wang Z Int J Colorectal Dis; 2024 Mar; 39(1):38. PubMed ID: 38492080 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer]. Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307 [No Abstract] [Full Text] [Related] [Next] [New Search]